Alta Wealth Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History

Alta Wealth Advisors’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$629K	Hold	1,008	–	–	0.17%	97
2026 Q1	$779K	Buy	1,008 +8	+0.8%	+$6.13K	0.25%	77
2025 Q4	$772K	Hold	1,000	–	–	0.26%	67
2025 Q3	$562K	Hold	1,000	–	–	0.2%	83
2025 Q2	$525K	Hold	1,000	–	–	0.25%	64
2025 Q1	$634K	Hold	1,000	–	–	0.29%	66
2024 Q4	$712K	Hold	1,000	–	–	0.31%	62
2024 Q3	$1.05M	Hold	1,000	–	–	0.48%	48
2024 Q2	$1.05M	Hold	1,000	–	–	0.52%	46
2024 Q1	$962K	Hold	1,000	–	–	0.49%	49
2023 Q4	$878K	Hold	1,000	–	–	0.49%	55
2023 Q3	$823K	Hold	1,000	–	–	0.5%	59
2023 Q2	$719K	Hold	1,000	–	–	0.42%	69
2023 Q1	$822K	Hold	1,000	–	–	0.52%	63
2022 Q4	$721K	Hold	1,000	–	–	0.49%	67
2022 Q3	$689K	Hold	1,000	–	–	0.49%	57
2022 Q2	$591K	Hold	1,000	–	–	0.41%	68
2022 Q1	$698K	Buy	+1,000	New	+$633K	0.41%	71

Other funds holding REGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Alta Wealth Advisors's REGN Position: Q2 2026 in Review

Alta Wealth Advisors held its Regeneron Pharmaceuticals (REGN) position steady in Q2 2026 at 1,008 shares worth $629K. The position accounts for 0.17% of the portfolio, ranked #97.

Alta Wealth Advisors first reported a position in REGN in Q1 2022 and has held it in 18 quarters since. The position peaked at $1.05M in Q3 2024. 1,333 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

Alta Wealth Advisors held 1,008 shares of Regeneron Pharmaceuticals worth $629K as of Q2 2026.
Alta Wealth Advisors left its Regeneron Pharmaceuticals share count unchanged in Q2 2026.
Regeneron Pharmaceuticals made up 0.17% of Alta Wealth Advisors's portfolio in Q2 2026, its #97 holding.
Alta Wealth Advisors first reported a position in Regeneron Pharmaceuticals in Q1 2022 and has held it in 18 quarters since.
Alta Wealth Advisors's Regeneron Pharmaceuticals position peaked at $1.05M in Q3 2024.
1,333 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Alta Wealth Advisors's 13F filing for Q2 2026, filed 30 Jul 2026.